Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina Cascone

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
The Oncologist|September 5, 2024
Proceedings of the 1st biannual bridging the gaps in lung cancer conferenceNarjust Florez, Sandip P Patel, Heather Wakelee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2018
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancerWon-Chul Lee, Lixia Diao, Jing Wang, et al.
Journal for Immunotherapy of Cancer|May 1, 2020
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohortKyle G Mitchell, Lixia Diao, Tatiana Karpinets, et al.
Lung Cancer (Amsterdam, Netherlands)|July 4, 2020
Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperativelyErin M Corsini, Qi Wang, Hai T Tran, et al.
Nature Medicine|May 31, 2025
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trialTina Cascone, Laura Bonanno, Florian Guisier, et al.
JTO Clinical and Research Reports|March 31, 2025
Longitudinal Tracking of <i>ALK</i>-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNASimon Heeke, Saumil Gandhi, Hai T Tran, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 20, 2024
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung CancerJonathan D Spicer, Tina Cascone, Murry W Wynes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLCPedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2024
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinomaKelsey L Corrigan, Ting Xu, Yuki Sasaki, et al.
Lung Cancer (Amsterdam, Netherlands)|January 17, 2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resectionNathaniel Deboever, Daniel J McGrail, Younghee Lee, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
The Oncologist|September 5, 2024
Proceedings of the 1st biannual bridging the gaps in lung cancer conferenceNarjust Florez, Sandip P Patel, Heather Wakelee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2018
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancerWon-Chul Lee, Lixia Diao, Jing Wang, et al.
Journal for Immunotherapy of Cancer|May 1, 2020
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohortKyle G Mitchell, Lixia Diao, Tatiana Karpinets, et al.
Lung Cancer (Amsterdam, Netherlands)|July 4, 2020
Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperativelyErin M Corsini, Qi Wang, Hai T Tran, et al.
Nature Medicine|May 31, 2025
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trialTina Cascone, Laura Bonanno, Florian Guisier, et al.
JTO Clinical and Research Reports|March 31, 2025
Longitudinal Tracking of <i>ALK</i>-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNASimon Heeke, Saumil Gandhi, Hai T Tran, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 20, 2024
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung CancerJonathan D Spicer, Tina Cascone, Murry W Wynes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLCPedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2024
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinomaKelsey L Corrigan, Ting Xu, Yuki Sasaki, et al.
Lung Cancer (Amsterdam, Netherlands)|January 17, 2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resectionNathaniel Deboever, Daniel J McGrail, Younghee Lee, et al.
Pageof 13